SCHEMBL27183159

SCHEMBL27183159

O=P(O)(O)OC[C@H]1O[C@@H](n2cnc3c(O)nc(S)nc32)[C@H](O)[C@@H]1O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 1/20 0.66
DNPH1 O43598 6/20 0.64
TAS1R3 Q7RTX0 4/20 0.64
TAS1R1 Q7RTX1 4/20 0.64
PRKAB2 O43741 1/20 0.64
TRPM2 O94759 1/20 0.64
LDHA P00338 1/20 0.64
ADRB2 P07550 1/20 0.64
FBP1 P09467 1/20 0.64
SRC P12931 1/20 0.64
ADORA1 P30542 1/20 0.64
P2RY2 P41231 1/20 0.64
P2RY1 P47900 1/20 0.64
PRKAG1 P54619 1/20 0.64
PRKAA2 P54646 1/20 0.64
PDE4D Q08499 1/20 0.64
KCNH2 Q12809 1/20 0.64
PRKAA1 Q13131 1/20 0.64
PDE3A Q14432 1/20 0.64
SMN1; SMN2 Q16637 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL188740 0.92 CA5A (0.68) CA5ADNPH1TAS1R3TAS1R1PRKAB2
Ammonia Solution, Strong SCHEMBL4362929 0.91 CA5A (0.67) CA5ADNPH1TAS1R3TAS1R1PRKAB2
SCHEMBL6848973 0.89 P2RY1 (0.67) CA5ADNPH1TAS1R3TAS1R1PRKAB2
E626 SCHEMBL19222125 0.89 CA5A (0.71) CA5ADNPH1TAS1R3TAS1R1PRKAB2
Triphosphate SCHEMBL11811171 0.88 CA5A (0.64) CA5ADNPH1TAS1R3TAS1R1PRKAB2
SCHEMBL1904667 0.88 CA5A (0.66) CA5ADNPH1TAS1R3TAS1R1PRKAB2
SCHEMBL31527983 0.86 IMPDH2 (0.67) CA5ADNPH1TAS1R3TAS1R1PRKAB2
SCHEMBL31527789 0.86 CA5A (0.62) CA5ADNPH1TAS1R3TAS1R1PRKAB2
SCHEMBL31527798 0.85 P2RY1 (0.69) P2RY1P2RY11
SCHEMBL25168081 0.85 DNPH1 (0.79) DNPH1TAS1R3TAS1R1PRKAB2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2026-04-30 US disclosed
EP-4593631-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME Mars, Incorporated (US) 2025-08-06 EP disclosed
CN-119968127-A Animal food compositions with improved palatability and customizable properties and methods of making the same 玛氏公司 2025-05-09 CN disclosed
WO-2024073025-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-04 WO disclosed
EP-4344552-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME MARS, INCORPORATED (US) 2024-04-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260114475-A1 ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME PIGS, TAS2R13, CEL CA5A 4259/4885DNPH1 1413/4885TAS1R3 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.